Calmark presents in the webinar “Strategic Routes for Entering the Chinese Life Science Market”

Calmark presents in the webinar “Strategic Routes for Entering the Chinese Life Science Market”

Nyheter
News
As a company that has recently entered the Chinese market, Calmark will share its experiences, tips and tricks so far, at the third China webinar hosted by the Swecare Foundation. The webinar will be held on 18 March at 8:30.

The China healthcare industry is ranked the second largest in the world behind the US and is growing at a consistently rapid rate. The third webinar in Swecare's series focusing on the Chinese healthcare market will discuss various options for market entry and offer first-hand insights from two Swedish companies that recently have ventured into the market.

Representatives of Nordic Match, financial advisors to Calmark, will cover various strategies for entering the Chinese life science and healthcare market, such as partnerships, JV, inbound M&A, direct investments and licensing.

Agenda:

08:30 – 08:35 Welcome and Introduction

Anna Riby – Swecare

08:35 – 09:05 What are the different strategic routes to consider when entering China?

Markus Dahlström, Partner, and Tony Wang, Partner, Nordic Match

09:05 - 09:15 Story-sharing from Calmark's China journey

Anna Söderlund, CEO, Calmark

09:15 – 09:25 Story-sharing from Vironova's China journey

Mohammed Homman, CEO, Vironova

09:25 – 09:45 Q&A, discussion and summary

Read more and register here. Participation is free.